There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Long-term sedation with midazolam or propofol in intensive care units (ICUs) has serious
adverse effects. Dexmedetomidine, an α(2)-agonist available for ICU sedation, may
reduce the duration of mechanical ventilation and enhance patient comfort.